WhatsApp
backNews Article

Manipal Health Enterprises Posts Record INR3,400 Crores Revenue in Q2 FY27 with 37% Volume Growth

EBITDA rises 30% to INR882 crores; Digital health revenue contributes 23% in H1 FY27; Sahyadri Hospitals EBITDA margin improves to 19.5% in Q2

Manipal Health Enterprises Limited posted its best-ever quarter in Q2 FY27 with revenues reaching INR3,400 crores, marking a 37% increase year-over-year. The company reported a 30% rise in EBITDA to INR882 crores and an average occupancy increase to 70%, supported by digital revenue contributing 23% of total revenue in H1 FY27. Sahyadri Hospitals reported a 13% sequential revenue growth in Q2 with EBITDA margin improving to 19.5%.

1 day ago|MANIPALHOS-1.87%
Manipal Health Enterprises LimitedMANIPALHOS544847Earnings Call Transcript

Manipal Health Enterprises Limited

Earnings Call Transcript

Manipal Health Enterprises Limited achieved its highest quarterly performance in Q2 FY27, recording revenues of INR3,400 crores, a 37% increase year-on-year. The company’s EBITDA grew by 30% to INR882 crores, supported by increased inpatient and outpatient volumes and higher occupancy rates.

Healthcare volumes drove growth with inpatient volumes up 35% and outpatient volumes up 27% year-on-year. Average occupancy improved from 65% in Q1 FY27 to 70% in Q2 FY27, maintaining an industry-leading average length of stay of 2.8 days.

Revenue per occupied bed per day excluding Sahyadri Hospitals was approximately INR77,000, marking over 8% growth year-on-year, while the network-wide average stood at INR70,600.

In the first half of FY27, Manipal Health reported revenue of INR6,490 crores (a 38% increase) and EBITDA of INR1,631 crores (up 28%), with a PAT of INR639 crores representing a 10% margin. Digital revenue accounted for 23% of total revenue in H1 FY27, driven by e-pharmacy (34,000 orders), telehealth solutions (38,000 virtual consultations), and AI-enabled chatbot interactions (24,000).

Centers of excellence specialties contributed 64.2% of revenue in H1 FY27, growing by 43%, led by oncology, neurology, and orthopedics. Investments included deploying the Da Vinci 5 robotic surgical system and launching advanced robotic-assisted orthopedic surgery.

Sahyadri Hospitals delivered Q2 FY27 revenue of INR375 crores (13% sequential growth) with EBITDA rising 26% quarter-on-quarter to INR73 crores. Its EBITDA margin improved to 19.5% in Q2 from 17.5% in Q1, ahead of FY26’s average margin of 15.5%. Digital revenues formed 11% of Sahyadri's revenue in H1 FY27.

Highlights

  • Q2 FY27 revenue at INR3,400 crores, up 37% year-on-year
  • Q2 FY27 EBITDA reached INR882 crores, a 30% increase year-on-year
  • Average admission occupancy rose to 70% in Q2 FY27 from 65% in Q1 FY27
  • Digital revenue accounted for 23% of total revenue in H1 FY27
  • Sahyadri Hospitals Q2 FY27 revenue grew 13% sequentially to INR375 crores
  • Sahyadri EBITDA margin improved to 19.5% in Q2 FY27 from 17.5% in Q1 FY27

Key Data Snapshot

Q2 FY27 RevenueINR3,400 crores
Q2 FY27 EBITDAINR882 crores
Q2 FY27 EBITDA Margin (excluding Sahyadri)27%
Q2 FY27 Network EBITDA Margin (including Sahyadri)26%
Average Occupancy Q2 FY2770%
Average Length of Stay2.8 days
Revenue per Occupied Bed per Day (excl. Sahyadri)INR77,000
Revenue per Occupied Bed per Day (Network)INR70,600
H1 FY27 RevenueINR6,490 crores
H1 FY27 EBITDAINR1,631 crores
H1 FY27 PATINR639 crores
Digital Revenue Contribution H1 FY2723%
Sahyadri Q2 FY27 RevenueINR375 crores
Sahyadri Q2 FY27 EBITDAINR73 crores},{

What happened

  • Manipal Health Enterprises reported record revenue of INR3,400 crores in Q2 FY27, increasing 37% year-on-year.
  • EBITDA grew 30% to INR882 crores, with margins excluding Sahyadri at 27%.
  • Inpatient volumes rose 35%, outpatient volumes rose 27%, and average occupancy increased to 70% during the quarter.

Financial performance

  • Total H1 FY27 revenue rose 38% year-on-year to INR6,490 crores with EBITDA at INR1,631 crores, up 28%.
  • PAT for H1 FY27 was INR639 crores, representing a net margin of 10%.
  • Digital health services contributed 23% of revenue in H1 FY27, comprising e-pharmacy, telehealth consultations, and AI-based chatbot interactions.

Operational performance

  • Centers of excellence contributed 64.2% of revenues in H1 FY27, driven by oncology, neurology, and orthopedics.
  • Recent technology investments include Da Vinci 5 robotic surgical system and robotic orthopedic surgery.
  • Sahyadri Hospitals achieved 13% quarter-on-quarter revenue growth to INR375 crores in Q2 FY27 with EBITDA margin improving to 19.5%.

More News on Earnings Call Transcript

View all

Latest corporate announcements and market updates in Earnings Call Transcript.

View all news
Manipal Health Enterprises Posts Record INR3,400 Crores | Stockk News